Skip to content

BenchSci vs Recursion

A side-by-side comparison of BenchSci and Recursion, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

BenchSci

Science

AI platform for preclinical drug-discovery research.

View BenchSci

Recursion

Science

AI-driven drug discovery on the Recursion OS platform.

View Recursion

At a glance

Feature comparison of BenchSci and Recursion
AttributeBenchSciRecursion
CategoryScienceScience
PricingPAIDPAID
LicenseProprietaryProprietary
DeploymentCloudCloud
PlatformsWebWeb
Model support (differs)Multi-modelSelf-contained (on-device)
Vendor (differs)BenchSciRecursion Pharmaceuticals

The honest brief

BenchSci

Built on a decade-curated Biological Evidence Knowledge Graph of 100M+ papers and figures, not a general LLM bolted onto literature search.

  • Grounds answers in curated biomedical evidence
  • Reduces unnecessary preclinical experiments
  • Integrates a customer's proprietary internal data
  • Adopted by top-10 pharma companies
  • Enterprise-only; pricing not public
  • Narrowly scoped to preclinical R&D
  • Requires onboarding with a dedicated team

Recursion

Runs a vast in-house automated wet lab generating millions of cell experiments weekly, feeding a 50+ petabyte dataset few rivals can match.

  • Recursion OS with LOWE language layer
  • Massive proprietary biology dataset
  • Natural-language target and compound queries
  • Public company with pharma partners
  • No self-serve product or API
  • Partner and internal use only
  • Opaque pricing
  • No approved drug yet